Literature DB >> 2536966

Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres.

T Matsumata1, T Kanematsu, K Takenaka, K Sugimachi.   

Abstract

Immediate recurrence in the hepatic remnant is sometimes evidenced after curative resection for treatment of hepatocellular carcinoma. One possible cause of this early recurrence is the multiple dissemination of tumor cells via the portal vein in the remnant liver as a result of surgical manipulations. In an attempt to prevent such recurrences, we performed ultrasonically guided, intraoperative portal embolization with starch microspheres in eight patients with hepatocellular carcinomas. These starch microspheres lodge only temporarily in the microvasculature, and there are no adverse effects, such as a rise in portal pressure or postoperative liver dysfunction. To date, there is no recurrence in any patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536966

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.

Authors:  Elie Oussoultzoglou; Philippe Bachellier; Edoardo Rosso; Radu Scurtu; Ioan Lucescu; Michel Greget; Daniel Jaeck
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

2.  The liver hanging manoeuvre.

Authors:  Guido Liddo; Emmanuel Buc; Ganesh Nagarajan; Masaaki Hidaka; Safi Dokmak; Jacques Belghiti
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

3.  Adverse impact of intermittent portal clamping on long-term postoperative outcomes in hepatocellular carcinoma.

Authors:  S Hao; S Chen; X Yang; C Wan
Journal:  Ann R Coll Surg Engl       Date:  2016-06-06       Impact factor: 1.891

Review 4.  Therapeutic modalities and prognostic factors for primary and secondary liver tumors.

Authors:  T Lehnert; G Otto; C Herfarth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

5.  Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study.

Authors:  Chi Leung Liu; Sheung Tat Fan; Siu Tim Cheung; Chung Mau Lo; Irene O Ng; John Wong
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

6.  Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?

Authors:  T Harada; K Matsuo; T Inoue; S Tamesue; T Inoue; H Nakamura
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

7.  Anterior Approach to Improve the Prognosis in HCC Patients Via Decreasing Dissemination of EpCAM+ Circulating Tumor Cells.

Authors:  Shenghua Hao; Shaofei Chen; Caixue Tu; Taotao Huang
Journal:  J Gastrointest Surg       Date:  2017-04-04       Impact factor: 3.452

Review 8.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

9.  Portal vein embolization with ethanol injection via a fine needle in dogs.

Authors:  M D Lu; L J Liang; J F Huang; W J Ye; Q S Yang; B G Peng; X Y Xie
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

10.  Impact of intermittent portal clamping on the early recurrence of hepatocellular carcinoma after surgery.

Authors:  Shenghua Hao; Shaofei Chen; Xiangwu Yang; Chidan Wan
Journal:  Surg Today       Date:  2016-03-02       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.